Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CactiCell is a multi-ingredient nutraceutical and dietary supplement developed by MaxxLife International (Maxxlife International Sdn. Bhd.). It is formulated as a premium blend of 12 organic ingredients, featuring Cactinea (a prickly pear cactus extract sourced from France) and Phytocelltec Solar Vitis (a Switzerland-sourced grape stem cell technology). The product is designed to support overall health through a dual-action approach: detoxification and cellular rejuvenation. Cactinea serves as a natural antioxidant and detoxifier to help eliminate metabolic toxins and waste, while the stem cell component aims to stimulate the regeneration of healthy cells and combat signs of aging. It is marketed for boosting vitality, enhancing wellness, and supporting systemic cellular health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CactiCell.